United States · FDA National Drug Code directory
Tekturna
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70839-300_130d24ec-4b3b-0978-e063-6394a90af0c8
- Product NDC
- 70839-300
- Form
- TABLET, FILM COATED
- Composition / generic term
- aliskiren hemifumarate
- Labeler
- LXO US Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20070305
- Source listing expiry
- 20261231
Source-listed ingredients
- ALISKIREN HEMIFUMARATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (70839-300-30) · 70839-300-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →